Medical School · Year 3 · Pediatrics · includes a quiz and discussion video

Seminar 16: Adolescent Medicine

Unit 3: Pediatrics Clerkship

Learning Objectives

1. Conduct the adolescent interview using the HEADSS psychosocial assessment framework
2. Understand adolescent confidentiality principles and legal considerations for minor consent
3. Recognize and manage common mental health disorders in adolescents including depression and anxiety
4. Screen for substance use using validated tools and implement brief intervention strategies
5. Address sexual and reproductive health needs including contraception counseling and STI screening
6. Identify eating disorders and understand their medical complications and management approaches

Lecture Outline

Section 1: Adolescent Development

Adolescent development encompasses dramatic transformations across physical, cognitive, and psychosocial domains that fundamentally reshape the individual from childhood to adulthood. Physical development follows predictable staging patterns, with girls typically experiencing breast development and growth spurts during early adolescence between ages 10-13, followed by menarche and slowing of linear growth during middle adolescence. Boys demonstrate a different temporal pattern, with testicular enlargement occurring in early adolescence, while the pubertal growth spurt and voice changes characteristically occur during middle adolescence between ages 14-16. Understanding these developmental trajectories helps clinicians recognize normal variation while identifying concerning deviations that may warrant further evaluation.

Cognitive development during adolescence represents a gradual transition from concrete operational thinking to formal operational thought with the capacity for abstract reasoning. Early adolescents demonstrate present-focused, concrete thinking patterns that influence their decision-making and health behaviors, often struggling to anticipate consequences of their actions. Middle adolescence brings emerging abstract thinking capabilities alongside characteristic risk-taking behaviors that reflect ongoing neurological maturation, particularly the developing prefrontal cortex. By late adolescence, individuals typically achieve more sophisticated future-oriented thinking with improved understanding of consequences, though executive function continues developing into the mid-twenties.

Psychosocial development during adolescence involves the complex interplay of identity formation, peer relationships, and evolving family dynamics. Early adolescents experience heightened self-consciousness while gravitating toward same-sex peer groups as they begin to individuate from their families, often initiating conflicts as they test boundaries. Middle adolescence brings experimentation with different identities and values, strong peer conformity, and active seeking of autonomy from parental authority. Late adolescence typically features consolidated identity formation, transition from conformity-driven peer relationships to more individualized friendships, and reconnection with family as the young person establishes their adult identity.

Clinical care of adolescents requires adaptation to their developmental stage through age-appropriate communication strategies. Confidentiality stands as essential for establishing trust and eliciting honest disclosure about sensitive health behaviors. Clinicians should employ concrete, specific language with early adolescents while acknowledging their emerging capacity for abstract discussion as they mature. Recognition of developmentally normal risk-taking behavior enables non-judgmental screening and intervention, while acknowledging the profound importance of peer relationships helps clinicians understand adolescent motivations and concerns.

<image>Panel A: Comparative timeline showing stages of pubertal development in males and females with Tanner staging markers. Panel B: Brain development diagram highlighting prefrontal cortex maturation from early adolescence through mid-twenties. Panel C: Illustration of psychosocial development stages showing changing peer and family relationship dynamics. Panel D: Clinical encounter depicting age-appropriate communication between provider and adolescent patient.</image>

Section 2: The Adolescent Interview

The adolescent interview requires deliberate structuring to facilitate honest communication about sensitive health topics while establishing trust between the clinician and young patient. Confidentiality forms the cornerstone of effective adolescent care, requiring clear explanation of its parameters and limits at the outset of the encounter. Clinicians should routinely spend time interviewing adolescents alone without parents present, demonstrating respect for their emerging autonomy while providing space for disclosure of sensitive information. A non-judgmental stance characterized by active listening without lecturing creates an atmosphere where adolescents feel safe discussing their concerns and behaviors.

The HEADSS assessment provides a comprehensive psychosocial screening framework that guides systematic evaluation of key life domains affecting adolescent health. Home assessment explores family composition, living situation, relationship quality, and safety concerns including exposure to domestic violence. Education and employment questions address school performance, attendance, relationships with teachers and peers, future goals, and for working adolescents, job satisfaction and safety. Eating assessment explores dietary patterns, weight concerns, and body image, while activities questioning examines hobbies, peer relationships, screen time, and extracurricular involvement.

The sensitive domains of HEADSS require particular attention to interviewing technique and appropriate follow-up questioning. Drug and substance use screening begins with questions about peer behavior before inquiring about the adolescent's own use, progressing through tobacco, alcohol, marijuana, and other substances. Sexuality assessment uses inclusive language to explore sexual orientation, gender identity, romantic relationships, sexual activity, contraceptive use, and concerns about consent or coercion. Suicide and safety screening directly asks about mood, depression, self-harm thoughts, suicidal ideation, and exposure to violence, with appropriate intensification of questions based on positive responses.

Understanding confidentiality limits ensures ethical practice and appropriate management of disclosed information. Mandatory reporting requirements apply to suspected abuse or neglect, requiring clinicians to break confidentiality while explaining this necessity to the adolescent. Active suicidal ideation typically necessitates involving parents or guardians in safety planning, though the clinician should discuss this with the adolescent before disclosure. Homicidal ideation invokes duty to warn potential victims, while some jurisdictions require partner notification for certain sexually transmitted infections. Clinicians must know their state-specific laws governing adolescent confidentiality across different health domains.

<image>Panel A: Clinical scene showing proper interviewing arrangement with adolescent alone in exam room, parent in waiting area. Panel B: Circular diagram illustrating HEADSS domains with expanding detail for each letter. Panel C: Flowchart depicting progression from open-ended screening questions to focused follow-up based on responses. Panel D: Decision tree showing confidentiality limits and required disclosure scenarios.</image>

Section 3: Adolescent Mental Health - Depression and Anxiety

Depression represents one of the most prevalent mental health conditions affecting adolescents, with approximately 10-15% of adolescents experiencing clinically significant depressive episodes. The presentation of adolescent depression frequently differs from adult depression, with irritability often predominating over reported sadness or hopelessness. Risk factors include family history of depression, personal or family history of trauma, chronic stress, and social isolation, while protective factors include strong family connections and peer support. Annual screening with validated instruments such as the Patient Health Questionnaire for Adolescents ensures early identification of depressive symptoms.

Treatment of adolescent depression typically involves evidence-based psychotherapy as first-line intervention, with medication added for moderate-to-severe cases or treatment-resistant depression. Cognitive behavioral therapy and interpersonal therapy have demonstrated efficacy in randomized controlled trials for adolescent depression. When pharmacotherapy is indicated, fluoxetine carries FDA approval for adolescent depression and represents the first-line selective serotonin reuptake inhibitor for this population. All SSRIs carry a black box warning regarding potential increased suicidality in adolescents, requiring close monitoring during treatment initiation and dose adjustments.

Anxiety disorders affect a substantial proportion of adolescents and frequently co-occur with depression, requiring comprehensive assessment and often combined treatment approaches. Generalized anxiety disorder presents with excessive, difficult-to-control worry across multiple domains including academic performance, social relationships, and health concerns. Social anxiety disorder manifests as intense fear of social situations involving potential scrutiny or judgment by others, often leading to avoidance behaviors that impair functioning. Panic disorder features unexpected, recurrent panic attacks with associated anticipatory anxiety and sometimes agoraphobic avoidance of situations where escape might be difficult.

Treatment of adolescent anxiety disorders follows a stepped-care approach beginning with psychoeducation and cognitive behavioral therapy. CBT for anxiety involves cognitive restructuring to address maladaptive thought patterns alongside graduated exposure to anxiety-provoking situations. For severe or treatment-resistant anxiety, SSRIs demonstrate efficacy and can be combined with ongoing psychotherapy. Benzodiazepines are generally avoided in adolescents due to concerns about dependence, cognitive effects, and potential misuse, though they may be considered for limited, specific situations under close supervision.

<image>Panel A: Comparison chart showing differences between adolescent and adult depression presentations with key distinguishing features. Panel B: Diagnostic algorithm for depression screening and assessment using PHQ-A scoring thresholds. Panel C: Brain diagram highlighting neurobiological pathways involved in depression and anxiety with medication targets. Panel D: Stepped care pyramid showing progression from psychoeducation through psychotherapy to combined treatment.</image>

Section 4: Suicide Assessment and Prevention

Suicide represents the second leading cause of death among adolescents, making routine screening and competent risk assessment essential skills for all clinicians caring for this population. Risk factors for adolescent suicide include previous suicide attempt (the strongest predictor), mental health disorders particularly depression and substance use, access to lethal means especially firearms, and recent significant stressors including relationship difficulties and academic problems. LGBTQ+ youth experience substantially elevated suicide risk, particularly those experiencing family rejection of their identity. Protective factors include family connectedness, school engagement, and having reasons for living and future goals.

Suicide assessment requires direct, unambiguous questioning about suicidal ideation, which does not increase risk and may actually be therapeutic by demonstrating concern. Clinicians should ask progressively specific questions exploring passive death wishes, active suicidal ideation, presence of a plan, access to means, and timeline for action. Assessment of intent includes questioning about preparation behaviors such as giving away possessions, writing notes, or researching methods. Protective factors and reasons for living should be explicitly explored as they inform risk stratification and safety planning.

Management of suicidal adolescents depends on assessed risk level and available resources for safe management. Low-risk patients without a plan, intent, or access to means may be appropriate for outpatient management with safety planning, lethal means restriction, and close follow-up. Moderate-risk patients typically require intensive outpatient treatment with daily check-ins, family involvement in supervision and means restriction, and clear crisis resources. High-risk patients with specific plans, intent, access to means, or inability to commit to safety require emergency psychiatric evaluation and likely hospitalization for stabilization.

Safety planning provides a structured intervention that adolescents and families can use when suicidal thoughts occur. The safety plan identifies personal warning signs preceding crisis, internal coping strategies the adolescent can employ independently, and people and places that provide distraction. It includes trusted individuals the adolescent can contact for help, lists crisis resources including the 988 Suicide and Crisis Lifeline, and documents steps to restrict access to lethal means. All family members should participate in means restriction, particularly securing firearms outside the home, which has demonstrated efficacy in reducing adolescent suicide completion.

<image>Panel A: Risk factor and protective factor balance scale showing elements influencing suicide risk assessment. Panel B: Flowchart depicting suicide screening progression from initial question through risk stratification. Panel C: Sample safety plan template showing all required components with placeholders for personalization. Panel D: Illustration of means restriction strategies including firearm storage and medication lockboxes.</image>

Section 5: Substance Use Screening and Intervention

Substance use among adolescents represents a significant public health concern with potential impacts on brain development, academic performance, and risk-taking behavior. Alcohol remains the most commonly used substance among adolescents, followed by marijuana, with both demonstrating neurobiological effects on the developing adolescent brain. Vaping and nicotine use have reached epidemic proportions among youth, with e-cigarette use particularly prevalent and serving as a gateway to traditional tobacco products. Prescription drug misuse, particularly opioids and stimulants, and illicit drug use including MDMA and hallucinogens affect a smaller but significant proportion of adolescents.

The CRAFFT screening tool provides a validated brief screening instrument specifically designed for adolescent substance use. The acronym explores Car use with an impaired driver, substance use to Relax or feel better, using Alone, Forgetting things while using, Friends or family expressing concern, and getting in Trouble while using. A score of two or more positive responses indicates need for further assessment and potential intervention. Screening should occur at every health encounter using a standardized approach, with the Part A car question asked of all adolescents regardless of their own substance use.

Brief intervention using motivational interviewing techniques provides an evidence-based approach for adolescents with problematic substance use. After asking permission to discuss substance use, clinicians assess the adolescent's readiness for change using stages of change framework concepts. Non-judgmental feedback about substance use patterns and associated risks maintains the therapeutic relationship while enhancing motivation for change. Motivational interviewing emphasizes eliciting change talk from the adolescent rather than prescribing behavior change, while negotiating patient-centered goals that respect adolescent autonomy.

Referral for substance use treatment depends on severity and level of need identified through screening and assessment. Brief intervention alone may suffice for adolescents with mild substance use who are motivated for change, with follow-up at subsequent visits to assess progress. Moderate substance use or failed brief intervention warrants referral to outpatient substance abuse treatment programs with experience treating adolescents. Severe substance use disorders, physical dependence, or failed outpatient treatment may require intensive outpatient programs or residential treatment, while acute intoxication or withdrawal requires appropriate medical management often in emergency or inpatient settings.

<image>Panel A: Bar graph showing prevalence rates of different substances among adolescents by age group. Panel B: CRAFFT questionnaire display with scoring interpretation guidelines. Panel C: Circular diagram of stages of change with appropriate intervention strategies for each stage. Panel D: Stepped care model showing progression from brief intervention through intensive treatment options.</image>

Section 6: Sexual and Reproductive Health

Comprehensive sexual and reproductive health assessment addresses the full spectrum of adolescent sexuality using inclusive, non-judgmental approaches. Assessment begins with questions about attraction and romantic interests using gender-neutral language that avoids assumptions about partner gender. Sexual behavior history explores types of sexual activity, number and gender of partners, and age of sexual debut if applicable. Contraception and pregnancy history documents current and past contraceptive use, method satisfaction, and any previous pregnancies or pregnancy scares. Assessment of safety explores consent, coercion, and partner violence, recognizing that adolescents may not initially disclose these experiences.

Contraception counseling emphasizes highly effective long-acting reversible contraception as first-line options for adolescents desiring pregnancy prevention. Contraceptive implants offer greater than 99% efficacy with protection lasting up to five years and minimal user compliance requirements, making them ideal for adolescents. Intrauterine devices provide similarly high efficacy with hormonal and copper options available, both safe for adolescents including those who have not been pregnant. Combined hormonal methods including pills, patches, and rings offer effective contraception with typical-use failure rates around 9%, making consistent use counseling essential. Barrier methods including condoms provide lower contraceptive efficacy but essential protection against sexually transmitted infections, and should be recommended alongside more effective contraceptive methods.

Sexually transmitted infection screening guidelines inform appropriate testing based on sexual activity patterns and risk factors. Sexually active females under 25 should receive annual screening for chlamydia and gonorrhea at minimum, with more frequent screening for those with new partners. Sexually active males should be tested if symptomatic or engage in male-to-male sexual contact, with annual chlamydia, gonorrhea, HIV, and syphilis testing recommended for men who have sex with men. HIV screening should be offered at least once to all adolescents with more frequent testing for those at higher risk. Hepatitis screening follows specific guidelines based on vaccination status and risk factors including injection drug use.

Care of LGBTQ+ adolescents requires particular attention to inclusive language, affirmation, and awareness of health disparities affecting this population. Clinicians should use gender-neutral language when asking about partners and avoid assumptions about sexual orientation or gender identity based on appearance. Mental health disparities including higher rates of depression, anxiety, and suicidality in LGBTQ+ youth reflect minority stress rather than inherent pathology. Affirming care that validates identity and supports family acceptance significantly improves mental health outcomes for LGBTQ+ adolescents. Clinicians should be prepared to provide resources for support groups and LGBTQ+-affirming mental health services when needed.

<image>Panel A: Comparison chart of contraceptive methods showing efficacy rates, duration, and key considerations for adolescents. Panel B: STI screening algorithm based on patient population and risk factors. Panel C: Timeline showing recommended screening intervals for different infections. Panel D: Illustration depicting inclusive clinical encounter with LGBTQ+ affirming language examples.</image>

Section 7: Eating Disorders

Eating disorders represent serious psychiatric conditions with significant medical morbidity and the highest mortality rate of any mental illness, requiring early recognition and comprehensive treatment. Anorexia nervosa features restriction of energy intake leading to significantly low body weight, intense fear of weight gain, and disturbed body image with undue influence of weight on self-evaluation. Bulimia nervosa involves recurrent episodes of binge eating followed by compensatory behaviors such as purging, excessive exercise, or fasting, typically occurring in individuals at normal weight. Binge eating disorder features recurrent binge episodes without compensatory behaviors and is often associated with overweight or obesity. Avoidant/restrictive food intake disorder presents with limited eating that causes nutritional deficiency or psychosocial impairment without the body image disturbance characteristic of anorexia.

Clinical recognition of eating disorders requires attention to both physical and behavioral warning signs that may emerge gradually. Physical signs include unexplained weight loss, amenorrhea or irregular menses, bradycardia, hypotension, and cold intolerance reflecting hypothermia and hypometabolism. Lanugo hair, parotid gland enlargement, and dental erosion may develop in patients with prolonged restriction or purging behaviors. Behavioral signs include food restriction, excessive exercise, hiding eating behaviors, frequent bathroom visits after meals, and preoccupation with food, calories, and body weight. Social withdrawal often accompanies eating disorder development as the illness consumes increasing cognitive and emotional resources.

Medical complications of eating disorders affect virtually every organ system and can be life-threatening. Cardiovascular complications include bradycardia, orthostatic hypotension, and arrhythmias that can cause sudden cardiac death, representing the leading cause of mortality in anorexia nervosa. Electrolyte abnormalities, particularly hypokalemia from purging, can precipitate cardiac arrhythmias and require close monitoring. Endocrine consequences include hypothalamic amenorrhea with associated low bone density that may not be fully reversible even with weight restoration. Gastrointestinal complications include delayed gastric emptying, constipation, and in severe cases, superior mesenteric artery syndrome.

Management of eating disorders requires a multidisciplinary team approach with treatment intensity matched to illness severity. Outpatient treatment suits patients who are medically stable with supportive families and includes nutritional rehabilitation, individual therapy (particularly cognitive behavioral therapy), and family-based treatment which has the strongest evidence base for adolescent anorexia. Higher levels of care including intensive outpatient programs, partial hospitalization, and residential treatment programs provide structured eating support for patients not progressing with outpatient care. Medical hospitalization is indicated for severe bradycardia, significant electrolyte abnormalities, hypotension, or acute food refusal requiring supervised refeeding while monitoring for refeeding syndrome.

<image>Panel A: Diagnostic criteria comparison showing distinguishing features of anorexia, bulimia, binge eating disorder, and ARFID. Panel B: Human body diagram illustrating multi-system medical complications of eating disorders. Panel C: Flow diagram showing decision points for different treatment levels of care. Panel D: Refeeding syndrome monitoring protocol with laboratory and clinical parameters.</image>

Section 8: Sports Medicine and Common Conditions

The preparticipation physical examination serves as a systematic evaluation to identify conditions that may affect safe athletic participation. History taking focuses on personal and family history of cardiac symptoms including syncope with exertion, chest pain, palpitations, and known heart conditions. Family history specifically screens for sudden cardiac death before age 50, which may indicate heritable conditions such as hypertrophic cardiomyopathy or long QT syndrome. Concussion history documents previous head injuries, recovery duration, and any lasting symptoms that might increase risk with subsequent injury. The physical examination emphasizes cardiovascular assessment including blood pressure, heart sounds for murmurs suggesting structural abnormalities, and musculoskeletal evaluation for injury risk.

Cardiac concerns during the preparticipation examination warrant additional evaluation before clearance for athletics. Syncope occurring during or immediately after exertion raises concern for arrhythmia or structural heart disease and requires cardiology evaluation before clearance. Exertional chest pain, shortness of breath disproportionate to activity level, or palpitations similarly warrant further workup. Concerning physical findings include blood pressure elevation, heart murmurs that increase with Valsalva or standing (suggesting hypertrophic cardiomyopathy), and irregular heart rhythms. Family history of sudden cardiac death in a young relative should prompt electrocardiography and possibly echocardiography before athletic participation.

Concussion management in adolescent athletes requires recognition of this clinical diagnosis and appropriate management to prevent long-term sequelae. Concussion diagnosis is clinical, based on symptoms including headache, confusion, amnesia, and balance disturbance following head impact, with imaging rarely indicated. Management involves both physical and cognitive rest, removing the athlete from play immediately and limiting activities that exacerbate symptoms. Return to play follows a graduated stepwise protocol beginning with light aerobic activity and progressing through sport-specific exercise, non-contact drills, and full-contact practice before return to competition. Second impact syndrome, though rare, represents catastrophic brain swelling when a second concussion occurs before complete recovery from the first, emphasizing the importance of full recovery before return to play.

The female athlete triad represents a spectrum of interrelated conditions affecting female athletes, now expanded to the concept of Relative Energy Deficiency in Sport. Low energy availability occurs when caloric intake is insufficient to support both athletic activity and normal physiological function. Menstrual dysfunction ranging from subtle abnormalities to complete amenorrhea results from energy deficiency affecting hypothalamic function. Low bone mineral density develops from the combined effects of hypoestrogenism and inadequate nutrition, increasing stress fracture risk. Prevention and treatment focus on adequate nutrition with energy intake matched to activity level, sometimes requiring reduction in training volume or intensity.

<image>Panel A: Preparticipation examination checklist with cardiac history red flags highlighted. Panel B: Electrocardiogram examples showing normal variant patterns versus concerning findings in athletes. Panel C: Stepwise return-to-play protocol diagram with timeline and activity progression. Panel D: Female athlete triad spectrum diagram showing relationships between energy availability, menstrual function, and bone health.</image>

Section 9: Confidentiality and Legal Considerations

Minor consent laws govern adolescents' legal ability to consent to specific health services without parental involvement, varying significantly by state jurisdiction. Most states allow minors to consent to testing and treatment for sexually transmitted infections without parental consent, recognizing that confidentiality facilitates care-seeking behavior. Contraceptive services are similarly available to minors in most states, including emergency contraception. Pregnancy-related care including prenatal care, delivery, and postpartum care is available without parental consent in virtually all states. Mental health and substance abuse treatment consent varies more widely by state, with some allowing minor consent and others requiring parental involvement.

The mature minor doctrine represents a legal principle allowing adolescents to provide valid consent for medical treatment when they demonstrate sufficient maturity to understand the nature and consequences of treatment. Application of mature minor doctrine requires individual assessment of the adolescent's decision-making capacity, which generally improves throughout adolescence. This doctrine is not universally recognized and varies by jurisdiction, requiring clinicians to understand their state-specific laws. Documentation of the adolescent's understanding and reasoning supporting capacity determination provides legal protection when applying mature minor principles.

Emancipated minor status confers legal adult status for medical decision-making upon adolescents who meet specific legal criteria. Legal marriage automatically emancipates minors in most jurisdictions, allowing independent consent for all medical care. Active duty military service similarly confers emancipated status regardless of age. Court-ordered emancipation typically requires demonstration of self-sufficiency and absence of need for parental support. Some jurisdictions recognize de facto emancipation for minors living independently and managing their own finances, though formal court determination provides clearer legal standing.

Documentation practices for adolescent care must balance the need for complete medical records against protection of confidential information from parent or guardian access. Confidential information including sexual health, substance use, and mental health may be documented in portions of the record with restricted access. Patient portals require careful management of proxy access to prevent inadvertent disclosure of confidential information to parents with portal accounts. Billing and explanation of benefits statements may reveal confidential services to parents, requiring discussion with adolescents about potential disclosure through this pathway. Clear establishment of preferred communication methods helps ensure confidential information reaches the adolescent directly.

<image>Panel A: State map showing variation in minor consent laws across jurisdictions with color coding by service type. Panel B: Decision flowchart for applying mature minor doctrine with documentation requirements. Panel C: Comparison table of emancipation criteria across different mechanisms. Panel D: Electronic health record screenshot showing proper configuration of confidential versus accessible record sections.</image>

Section 10: Transition to Adult Care

Transition from pediatric to adult healthcare represents a planned, purposeful process that prepares adolescents and young adults for independent management of their health. Transition planning should begin in early adolescence around ages 12-14, when the concept is introduced and foundational health literacy begins developing. Middle adolescence brings progressive transfer of responsibility for health management tasks, with adolescents increasingly managing appointments, medications, and communication with providers. Late adolescence and young adulthood features the actual transfer of care, ideally completed by age 18-21 depending on the individual's condition and readiness.

Skill development for successful healthcare transition encompasses self-advocacy, medical knowledge, and healthcare navigation competencies. Self-advocacy skills include the ability to describe one's health conditions, communicate symptoms and concerns to providers, and participate actively in healthcare decisions. Medical knowledge encompasses understanding of one's diagnoses, medications including names, doses, and purposes, and recognition of warning signs requiring medical attention. Healthcare navigation involves scheduling appointments, communicating with the healthcare system, managing prescription refills, and understanding health insurance.

Special populations face unique transition challenges requiring additional planning and support. Adolescents with chronic illnesses often have complex care needs and longstanding relationships with pediatric providers, making transition particularly challenging. Young adults with intellectual disabilities may require establishment of guardianship or supported decision-making arrangements before age 18. Youth aging out of foster care lose access to case management support and may experience insurance disruptions, requiring proactive planning. Adolescents with mental health conditions require particular attention to continuity as disruption in care increases risk of decompensation.

Barriers to successful transition include healthcare system factors, insurance complexities, and individual readiness issues. Insurance changes at age 18 or 26 may disrupt coverage and require proactive planning to ensure continuous access to care. Finding adult providers experienced with pediatric-onset conditions presents challenges, particularly for rare diseases managed primarily in pediatric centers. Knowledge gaps occur when medical records are not comprehensively transferred and adolescents cannot independently provide their full medical history. Warm handoffs with joint visits or direct communication between pediatric and adult providers facilitate successful transfer of care and relationship building.

<image>Panel A: Timeline showing transition planning milestones from age 12 through young adulthood with key activities at each stage. Panel B: Checklist of transition readiness skills with assessment and teaching tools. Panel C: Case vignette illustrations showing unique transition challenges for different special populations. Panel D: Diagram of warm handoff process showing communication pathways between pediatric and adult healthcare teams.</image>

Summary

• HEADSS assessment provides a comprehensive psychosocial screening framework exploring Home, Education, Eating, Activities, Drugs, Sexuality, and Suicide/Safety domains essential for adolescent care
• Confidentiality is essential for adolescent trust with clear explanation of limits required upfront; minors can generally consent for STI testing, contraception, and often mental health and substance abuse services
• Adolescent depression frequently presents with irritability rather than sadness; annual screening recommended with fluoxetine as first-line SSRI with black box warning monitoring
• Suicide assessment requires direct questioning about ideation, plan, means, and intent; safety planning includes means restriction, trusted contacts, and crisis resources
• CRAFFT screening provides validated substance use assessment with score of two or more positive responses indicating need for further assessment and intervention
• Long-acting reversible contraception including implants and IUDs represents most effective pregnancy prevention; condoms essential for STI prevention regardless of contraceptive method
• Sexually transmitted infection screening includes annual chlamydia and gonorrhea testing for sexually active females under 25; more frequent testing for men who have sex with men
• Eating disorders cause multi-system medical complications including bradycardia, electrolyte abnormalities, and bone density loss requiring multidisciplinary treatment
• Female athlete triad encompasses low energy availability, menstrual dysfunction, and low bone density now recognized as Relative Energy Deficiency in Sport
• Transition planning begins in early adolescence and develops self-advocacy, medical knowledge, and navigation skills for independent adult healthcare management

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown